Futurity September 20, 2022
Andrew Myers-Stanford

A small, autonomous device with a stretchable and flexible sensor that adheres to the skin can measure the changing size of tumors below the surface, a new study with mice shows.

The non-invasive, battery-operated device is sensitive to one-hundredth of a millimeter (10 micrometers) and can beam results to a smartphone app wirelessly in real time with the press of a button.

In practical terms, the researchers say, the device—dubbed FAST for “Flexible Autonomous Sensor measuring Tumors”—represents a wholly new, fast, inexpensive, hands-free, and accurate way to test the efficacy of cancer drugs. On a grander scale, it could lead to promising new directions in cancer treatment. The device is detailed in a paper in Science Advances.

Each year researchers...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Technology, Wearables
A Wearable Tech Gives Pharmas & Therapists Better Feel for Changes in Mental Health
Common remote patient monitoring tools
Smarter Aging: The Importance of Health Tech Planning
Biolinq Snags $58M for ‘Smallest Biosensor in the World’
Biolinq Secures $58M to Advance Continuous Glucose Monitoring Patch

Share This Article